Lab Profile.txt

3.5-5.0 mEq/L

132-146 mEq/L

136-145 mEq/L

98-106 mEq/L

98-111 mEq/L

23-30 mEq/L

23-31 mEq/L

20-29 mEq/L

70-110 mg/dL

4.1-5.9 mmol/L

82-115 mg/dL

4.6-6.4 mmol/L

75-121 mg/dL

4.2-6.7 mmol/L

0.5-1.1 mg/dL

44-97 µmol/L

0.6-1.2 mg/dL

53-106 µmol/L

0.6-1.3 mg/dL

53-115 µmol/L

0.6-1.2 mg/dL

53-106 µmol/L

0.8-1.3 mg/dL

71-115 µmol/L

1.0-1.7 mg/dL

88-150 µmol/L

10-20 mg/dL

2.1- 7.1 mmol/L

8-23 mg/dL

2.9- 8.2 mmol/L

10-31 mg/dL

3.6-11.1 mmol/L

0.9 - 1.3

A high INR level such as INR=5 indicates that there is a high chance of bleeding, whereas if the INR=0.5 then there is a high chance of having a clot. Normal range for a healthy person is 0.9–1.3, and for people on warfarin therapy, 2.0–3.0, although the target INR may be higher in particular situations, such as for those with a mechanical heart valve, or bridging warfarin with a low-molecular weight heparin (such as enoxaparin) perioperatively.

The prothrombin time (PT) and its derived measures of prothrombin ratio (PR) and international normalized ratio (INR) are measures of the extrinsic pathway of coagulation. This test is also called "ProTime INR" and "INR PT". They are used to determine the clotting tendency of blood, in the measure of warfarin dosage, liver damage, and vitamin K status. PT measures factors I (fibrinogen), II (thrombin), V, VII, and X. It is used in conjunction with the activated partial thromboplastin time (aPTT) which measures the intrinsic pathway.

11-12.5

The reference range for prothrombin time is usually around 10-14 seconds, and the INR in absence of anticoagulation therapy is 0.8-1.2. The target range for INR in anticoagulant use (e.g. warfarin) is 2 to 3. In some cases, if more intense anticoagulation is thought to be required, the target range may be 2.5-3.5.

The prothrombin time (PT) and its derived measures of prothrombin ratio (PR) and international normalized ratio (INR) are measures of the extrinsic pathway of coagulation. This test is also called "ProTime INR" and "INR PT". They are used to determine the clotting tendency of blood, in the measure of warfarin dosage, liver damage, and vitamin K status. PT measures factors I (fibrinogen), II (thrombin), V, VII, and X. It is used in conjunction with the activated partial thromboplastin time (aPTT) which measures the intrinsic pathway.

85%-100%

1:1.1 patient-control ratio

30-40 sec

The prothrombin time (PT) and its derived measures of prothrombin ratio (PR) and international normalized ratio (INR) are measures of the extrinsic (fibrin in bloood) pathway of coagulation. This test is also called "ProTime INR" and "INR PT". They are used to determine the clotting tendency of blood, in the measure of warfarin dosage, liver damage, and vitamin K status. PT measures factors I (fibrinogen), II (thrombin), V, VII, and X. It is used in conjunction with the activated partial thromboplastin time (aPTT) which measures the intrinsic (collogen on cell wall) pathway.

5,000-10,000/mm³

117-155 g/L

aka 11.7 or 12 g/dL

117-160 g/L

aka 11.7 or 12 g/dL

117-161 g/L

aka 11.7 or 12 g/dL

132-173 g/L

131-172 g/L

126-174 g/L

aka 12.6 or 13 g/dL

35%-45%

37%-47%

42%-52%

39%-50%

37%-51%